skip to Main Content
Dr. Sapna Syngal in a portait photo in her office

GENERATE Trial Expands Eligibility

Dr. Sapna Syngal explains the expanded eligibility standards for the GENERATE Study for genetic testing of pancreatic cancer patients and relatives.

Dr. Manuel Hidalgo

COMBATing Pancreatic Cancer

Dr. Manuel Hidalgo explains the COMBAT trial, which combines immunotherapy, a checkpoint inhibitor, and chemotherapy to attack pancreatic cancer.

Precancerous pancreatic cells in mice

A New Drug to Target Cancer Cell Enzymes

This trial remains active but is no longer recruiting participants. In patients with metastatic pancreatic cancer, researchers are comparing FOLFIRINOX, the standard treatment, with FOLFIRINOX plus CPI-613, a new drug that works on enzymes involved in cancer cell energy metabolism. Target: Enzymes Mitochondria are components within a cell that are responsible for generating the energy…

Back To Top